Dipeptidyl peptidase‐4 inhibitors as preferable oral hypoglycemic agents in terms of treatment satisfaction: Results from a multicenter, 12‐week, open label, randomized controlled study in Japan (PREFERENCE 4 study)

AIMS/INTRODUCTION: To compare the treatment satisfaction of four classes of oral hypoglycemic agents (OHAs): dipeptidyl peptidase‐4 (DPP‐4) inhibitors, α‐glucosidase inhibitors (αGI), biguanides (BG) and sulfonylureas (SU), which are common initial treatments for type 2 diabetes mellitus patients in...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishii, Hitoshi, Hayashino, Yasuaki, Akai, Yasuhiro, Yabuta, Matahiro, Tsujii, Satoru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754532/
https://www.ncbi.nlm.nih.gov/pubmed/28296349
http://dx.doi.org/10.1111/jdi.12659

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754532/
https://www.ncbi.nlm.nih.gov/pubmed/28296349
http://dx.doi.org/10.1111/jdi.12659

Ejemplares similares